Koo, Doyeon http://orcid.org/0000-0001-9877-7237
Cheng, Xiao
Udani, Shreya
Baghdasarian, Sevana
Zhu, Dashuai http://orcid.org/0000-0002-4645-5786
Li, Junlang
Hall, Brian
Tsubamoto, Natalie
Hu, Shiqi http://orcid.org/0000-0002-8570-3439
Ko, Jina http://orcid.org/0000-0002-4941-4234
Cheng, Ke http://orcid.org/0000-0001-7082-6893
Di Carlo, Dino http://orcid.org/0000-0003-3942-4284
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R21GM142174)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL144002, R01HL146153)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
American Heart Association (AHA19EIA34660286)
Article History
Received: 14 July 2023
Accepted: 24 May 2024
First Online: 7 June 2024
Competing interests
: D.D. and the University of California have financial interests in Partillion Bioscience, which commercialized the nanovial technology. The remaining authors declare no competing interests.